New pill could boost red blood cells in sickle cell patients
Disease control
Not yet recruiting
This study tests an experimental drug called SIL-8301 (senicapoc) in about 105 adults with sickle cell disease who have severe anemia and few pain crises. Participants take the drug or a placebo daily for 24 weeks, while continuing their usual hydroxyurea treatment. The main goal…
Phase: PHASE2 • Sponsor: Biossil Inc. • Aim: Disease control
Last updated May 06, 2026 16:03 UTC